Jos van der Kaa

1.2k total citations · 1 hit paper
14 papers, 946 citations indexed

About

Jos van der Kaa is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jos van der Kaa has authored 14 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jos van der Kaa's work include T-cell and B-cell Immunology (5 papers), CRISPR and Genetic Engineering (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Jos van der Kaa is often cited by papers focused on T-cell and B-cell Immunology (5 papers), CRISPR and Genetic Engineering (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Jos van der Kaa collaborates with scholars based in Netherlands, United States and United Kingdom. Jos van der Kaa's co-authors include Daniela Pietrobon, Rune R. Frants, Michel D. Ferrari, Rob C. G. van de Ven, Tommaso Pizzorusso, Ludo A. M. Broos, Arn M. J. M. van den Maagdenberg, Simon Kaja, Tiziana Cesetti and Jaap J. Plomp and has published in prestigious journals such as Neuron, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jos van der Kaa

14 papers receiving 923 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression

2004 517 citations Arn M. J. M. van den Maagdenberg, Daniela Pietrobon et al. Neuron profile →

Peers

Countries citing papers authored by Jos van der Kaa

Since Specialization

Citations

This map shows the geographic impact of Jos van der Kaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos van der Kaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos van der Kaa more than expected).

Fields of papers citing papers by Jos van der Kaa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos van der Kaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos van der Kaa. The network helps show where Jos van der Kaa may publish in the future.

Co-authorship network of co-authors of Jos van der Kaa

This figure shows the co-authorship network connecting the top 25 collaborators of Jos van der Kaa. A scholar is included among the top collaborators of Jos van der Kaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos van der Kaa. Jos van der Kaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A dystrophic Duchenne mouse model for testing human antisense oligonucleotides 2018 ·PLoS ONE ·Marcel H. A. M. Veltrop, Laura Van de Vliet, Margriet Hulsker, Jill Claassens, Conny Brouwers, Cor Breukel, Jos van der Kaa, Margot M. Linssen, Johan T. den Dunnen, Sjef Verbeek, Annemieke Aartsma‐Rus, Maaike van Putten	46
2	A dystrophic Duchenne mouse model for testing human antisense oligonucleotides 2016 ·Neuromuscular Disorders ·Marcel H. A. M. Veltrop, (unknown), Margriet Hulsker, Jill Claassens, Conny Brouwers, Cor Breukel, Jos van der Kaa, Margot M. Linssen, JT den Dunnen, J. Sjef Verbeek, Annemieke Aartsma‐Rus, Maaike van Putten	2
3	Involvement of Fcα/μ Receptor in IgM Anti-Platelet, but Not Anti–Red Blood Cell Autoantibody Pathogenicity in Mice 2015 ·The Journal of Immunology ·(unknown), Dan Su, Cor Breukel, Laurent Detalle, Jill Claassens, Jos van der Kaa, Shozo Izui, J. Sjef Verbeek, Jean‐Paul Coutelier	1
4	CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis 2015 ·Arthritis Research & Therapy ·(unknown), Hans P. Kiener, Birgit Niederreiter, (unknown), Jos van der Kaa, Valeria Ramaglia, Ramon Arens, Josef S Smolen, Marina Botto, Paul P. Tak, J. Sjef Verbeek, Jörg Hamann	23
5	FcγRIIb on Myeloid Cells Rather than on B Cells Protects from Collagen-Induced Arthritis 2014 ·The Journal of Immunology ·(unknown), (unknown), Patrick S. Asmawidjaja, Jos van der Kaa, Anne‐Marie Mus, (unknown), Jill Claassens, Cor Breukel, Conny Brouwers, Sara M. Mangsbo, Péter Boross, Erik Lubberts, J. Sjef Verbeek	14
6	Generation of Embryonic Stem Cells and Mice for Duchenne Research 2013 ·PLoS Currents ·Marcel H. A. M. Veltrop, Jos van der Kaa, Jill Claassens, Laura Van de Vliet, Sjef Verbeek, Annemieke Aartsma‐Rus	12
7	Antibody-Independent Thrombocytopenia in Lactate Dehydrogenase-Elevating Virus-Infected Mice 2012 ·Journal of Virology ·Dan Su, (unknown), (unknown), Laurent Detalle, Jos van der Kaa, J. Sjef Verbeek, Bernhard Ryffel, Jean‐Paul Coutelier	4
8	The Inhibiting Fc Receptor for IgG, FcγRIIB, Is a Modifier of Autoimmune Susceptibility 2011 ·The Journal of Immunology ·Péter Boross, (unknown), Javier Martín-Ramírez, (unknown), Francesco Carlucci, Roelof Flierman, Jos van der Kaa, Cor Breukel, Jill Claassens, Marcel Camps, Erik Lubberts, Daniela Salvatori, Maria Pia Rastaldi, Ferry Ossendorp, Mohamed R. Daha, H. Terence Cook, Shozo Izui, Marina Botto, J. Sjef Verbeek	88
9	Highly B lymphocyte‐specific tamoxifen inducible transgene expression of CreER^T2 by using the LC‐1 locus BAC vector 2009 ·genesis ·Péter Boross, Cor Breukel, Pieter Fokko van Loo, Jos van der Kaa, Jill Claassens, Hermann Bujard, Kai Schönig, J. Sjef Verbeek	10
10	Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration 2008 ·The Journal of Immunology ·Henrike Veninga, (unknown), Robert M. Hoek, Manja Wobus, Elke Wandel, Jos van der Kaa, Martin van der Valk, Alex F. de Vos, Hannelore Haase, Bronwyn M. Owens, Tom van der Poll, René A. W. van Lier, J. Sjef Verbeek, Gabriela Aust, Jörg Hamann	59
11	Destructive Arthritis in the Absence of Both FcγRI and FcγRIII 2008 ·The Journal of Immunology ·Péter Boross, P.L. van Lent, Javier Martín-Ramírez, Jos van der Kaa, (unknown), Jill Claassens, Wim B. van den Berg, (unknown), J. Sjef Verbeek	37
12	Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation 2006 ·Atherosclerosis ·Valérie Ferreira, Ko Willems van Dijk, Albert K. Groen, Rogier M. Vos, Jos van der Kaa, Marion J. Gijbels, Louis M. Havekes, Hans Pannekoek	68
13	A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression breakdown → 2004 ·Neuron ·Arn M. J. M. van den Maagdenberg, Daniela Pietrobon, Tommaso Pizzorusso, Simon Kaja, Ludo A. M. Broos, Tiziana Cesetti, Rob C. G. van de Ven, Angelita Tottene, Jos van der Kaa, Jaap J. Plomp, Rune R. Frants, Michel D. Ferrari	517
14	Generation of Transgenic Mice and Germline Transmission of a Mammalian Artificial Chromosome Introduced into Embryos by Pronuclear Microinjection 2000 ·Chromosome Research ·(unknown), (unknown), (unknown), Jos van der Kaa, (unknown), Gerard Platenburg, Frank Pieper, Carl F. Perez, Frank R. Jirik, (unknown)	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact